Mon, Sep 1, 2014, 10:45 AM EDT - U.S. Markets closed for Labor Day

Recent

% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • safari93 safari93 May 22, 2013 4:47 AM Flag

    Brean Murray raised target

    Analysts at Brean Murray increased their price target on shares of Onyx Pharmaceuticals (NASDAQ: ONXX) to $115.00 in a research report issued to clients and investors on Monday, ARN reports.

    Several other analysts have also recently commented on the stock. Analysts at UBS AG raised their price target on shares of Onyx Pharmaceuticals from $102.00 to $110.00 in a research note to investors on Wednesday, May 8th. They now have a “buy” rating on the stock. Separately, analysts at Leerink Swann raised their price target on shares of Onyx Pharmaceuticals from $95.00 to $112.00 in a research note to investors on Wednesday, May 8th. Finally, analysts at Barclays Capital raised their price target on shares of Onyx Pharmaceuticals from $93.00 to $98.00 in a research note to investors on Wednesday, May 8th. They now have an “overweight” rating on the stock.

    Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Onyx Pharmaceuticals presently has an average rating of “Buy” and an average price target of $102.33.

    Onyx Pharmaceuticals (NASDAQ: ONXX) traded up 0.83% on Monday, hitting $96.44. Onyx Pharmaceuticals has a 1-year low of $41.26 and a 1-year high of $101.57. The stock’s 50-day moving average is currently $89.26. The company’s market cap is $7.015 billion.

    Onyx Pharmaceuticals (NASDAQ: ONXX) last issued its quarterly earnings data on Tuesday, May 7th. The company reported ($0.19) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.47) by $0.28. The company had revenue of $145.50 million for the quarter, compared to the consensus estimate of $134.36 million. During the same quarter last year, the company posted ($0.68) earnings per share. Onyx Pharmaceuticals’s revenue was up 102.0% compared to the same quarter last year. On average, analysts predict that Onyx Pharmaceuticals will post $-1.72 earnings per share for the current fiscal year.

 
ONXX
124.700.00(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avago Technologies Limited
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT